Jain A, Myers G H, Sapin P M, O'Rourke R A
Division of Cardiology, University of Texas Health Science Center-San Antonio 78284.
J Am Coll Cardiol. 1993 Dec;22(7):1816-20. doi: 10.1016/0735-1097(93)90763-q.
This study was conducted to determine the diagnostic yield and risks of a symptom-limited treadmill exercise test before hospital discharge.
Currently, predischarge low level and 6-week symptom-limited exercise treadmill tests are recommended for risk stratification after myocardial infarction. However, few data exist on the safety and value of a predischarge symptom-limited exercise test.
We utilized a modified Bruce protocol starting at 1.7 mph and 0 grade with 3-min stages in 150 consecutive patients 6.4 +/- 3.1 days after myocardial infarction. Each exercise test was interpreted for duration, symptoms and ST segment changes at the low level (70% of predicted heart rate) and symptom-limited end point.
There were no complications related to the symptom-limited exercise tests. The test results were positive in only 23% of the patients at the low level end point, but were positive in 40% of the patients at the later symptom-limited end point (p < 0.001). During a mean follow-up period of 15 +/- 5 months in 138 patients (92%), 50 patients (36%) had a cardiac event. Of the patients with a cardiac event, significantly more (p < 0.001) had a positive exercise test at the symptom-limited end point (31 vs. 16 patients). Five patients with a negative and 14 patients with a nondiagnostic symptom-limited exercise test had an event.
In patients with uncomplicated myocardial infarction, we demonstrated the safety of an early symptom-limited treadmill exercise test. Symptom-limited exercise tests will identify more patients with inducible ischemia who are at risk of future cardiac events and who may benefit from early intervention.
本研究旨在确定出院前症状限制性平板运动试验的诊断率及风险。
目前,推荐在心肌梗死后进行出院前低水平及6周症状限制性运动平板试验以进行危险分层。然而,关于出院前症状限制性运动试验的安全性和价值的数据较少。
我们采用改良的布鲁斯方案,起始速度为1.7英里/小时,坡度为0级,每3分钟增加一级,对150例心肌梗死后6.4±3.1天的连续患者进行试验。对每次运动试验在低水平(预计心率的70%)和症状限制性终点时的持续时间、症状及ST段变化进行解读。
症状限制性运动试验未出现相关并发症。在低水平终点时,仅23%的患者试验结果为阳性,但在后期症状限制性终点时,40%的患者试验结果为阳性(p<0.001)。在138例患者(92%)平均15±5个月的随访期内,50例患者(36%)发生了心脏事件。在发生心脏事件的患者中,在症状限制性终点时运动试验为阳性的患者显著更多(p<0.001)(31例对16例)。5例运动试验阴性和14例运动试验未明确诊断的患者发生了事件。
在无并发症的心肌梗死患者中,我们证明了早期症状限制性平板运动试验的安全性。症状限制性运动试验将识别出更多有诱发性缺血且有未来心脏事件风险、可能从早期干预中获益的患者。